New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 28, 2014
08:28 EDTELGXEndologix price target lowered to $17 from $20 at Stifel
Stifel reduced its price target on Endologix after the company reported lower than expected Q4 revenue and provided lower than expected 2014 revenue guidance. However, the firm remains confident that the company can return to 20%+ sustainable growth next year, and keeps a Buy rating on the shares.
News For ELGX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 3, 2016
16:03 EDTELGXEndologix completes merger with TriVascular Technologies
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use